Washington, DC – WEBWIRE – Tuesday, April 28, 2015 IDSA continues to wage a campaign of denial about chronic Lyme in the face of growing scientific evidence that a very […]
[embedded content] According to the results of a new study, teens were able to purchase potentially dangerous supplements at a variety of health food stores across the US, despite labels […]
VANCOUVER, BC–(Marketwired – April 29, 2015) – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its current lead compound APC […]
Illumina, one of the most important companies in biomedicine, is still barely known to the public. But scientists, diagnostics makers, physicians, and Wall Street look at the company with a […]
• VesselNavigator has been designed for use in conjunction with Philips interventional X-ray systems to guide catheters during treatment of vascular disease. • Major reduction of contrast medium (70%) demonstrated […]
New Business Pulse Focuses on CDC’s Efforts to Protect American Workers’ Heart Health ATLANTA, GA–(Marketwired – April 29, 2015) – Nearly 800,000 Americans die each year from heart disease, stroke […]
New York State has begun accepting applications for its medical marijuana licenses this week. Applicants can submit questions through May 5th and the Department of Health Services (DOH) must answer […]
Once again, after decades of common use, a frequently implanted device has been found to confer no benefit whatsoever over a much less invasive therapy. Cardiologists and radiologists often implant the device, […]
WASHINGTON–(BUSINESS WIRE)–The Biotechnology Industry Organization (BIO) today releases the following statement on the 21st Century Cures Initiative discussion draft shared by Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), Rep. […]
Healthcare investment firm OrbiMed manages over $14 billion in public and private equity, nearly $1.4 billion of which is focused on Asia. With 23 private equity investments in Asia, OrbiMed […]
